Who owns CorMedix Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CRMD from SEC Form 13F filings across 193 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 193 institutions disclosed 44.0M shares of CorMedix Inc. worth $345.5M — about 56.1% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
193
13F holders
$345.5M
value, 2026 filers
56.1%
of shares outstanding (44.0M sh)
32
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CRMD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.3M | $49.6M | 0.0% | 8.1% | +6.0% |
| 2 | Deep Track Capital, LP | 6.3M | $49.3M | 0.7% | 8% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | $24.6M | 0.0% | 4% | +0.2% |
| 4 | STATE STREET CORP | 2.3M | $18.2M | 0.0% | 3% | +5.7% |
| 5 | ROYCE & ASSOCIATES LP | 2.2M | $17.1M | 0.1% | 2.8% | +15.3% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $15.3M | 0.0% | 2.5% | +7.2% |
| 7 | UBS Group AG | 1.9M | $14.7M | 0.0% | 2.4% | +22.1% |
| 8 | OBERWEIS ASSET MANAGEMENT INC/ | 1.3M | $10.4M | 0.2% | 1.7% | +9.3% |
| 9 | Alyeska Investment Group, L.P. | 850,000 | $6.7M | 0.0% | 1.1% | 0.0% |
| 10 | MARSHALL WACE, LLP | 779,535 | $6.1M | 0.0% | 1% | +55.0% |
| 11 | NORTHERN TRUST CORP | 756,430 | $5.9M | 0.0% | 1% | +18.6% |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLC | 708,604 | $5.6M | 0.0% | 0.9% | -4.6% |
| 13 | Pacer Advisors, Inc.NEW | 633,978 | $5.0M | 0.0% | 0.8% | new |
| 14 | HRT FINANCIAL LP | 625,558 | $4.9M | 0.0% | 0.8% | +113.9% |
| 15 | Trexquant Investment LP | 623,797 | $4.9M | 0.0% | 0.8% | +11.3% |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 618,172 | $4.9M | 0.0% | 0.8% | +2.5% |
| 17 | ARMISTICE CAPITAL, LLCNEW | 500,000 | $3.9M | 0.0% | 0.6% | new |
| 18 | VANGUARD FIDUCIARY TRUST CO | 484,322 | $3.8M | 0.0% | 0.6% | -4.2% |
| 19 | GOLDMAN SACHS GROUP INC | 466,393 | $3.7M | 0.0% | 0.6% | -8.8% |
| 20 | RAYMOND JAMES FINANCIAL INC | 446,142 | $3.5M | 0.0% | 0.6% | +35.9% |
| 21 | Hennion & Walsh Asset Management, Inc. | 438,629 | $3.4M | 0.1% | 0.6% | +150.6% |
| 22 | BRIDGEWAY CAPITAL MANAGEMENT, LLCNEW | 434,132 | $3.4M | 0.1% | 0.6% | new |
| 23 | Palisades Investment Partners, LLC | 426,543 | $3.3M | 1.0% | 0.5% | -30.1% |
| 24 | MORGAN STANLEY | 423,341 | $3.3M | 0.0% | 0.5% | -2.8% |
| 25 | KENNEDY CAPITAL MANAGEMENT LLC | 419,284 | $3.3M | 0.1% | 0.5% | -37.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.